US Support For Waiving COVID-19 Vaccine Patent Rights Puts Pressure On Drugmakers – But What Would A Waiver Actually Look Like?
May 10, 2021 at 10:44 AM EDT
The U.S. and Europe are debating waiving patent rights for COVID-19 vaccines, a move that could allow more companies to produce the vaccine around the world. But it’s not as simple as it might sound.
